Increased expression of 3-hydroxyanthranilate 3,4-dioxygenase gene in brain of epilepsy-prone E1 mice

Molecular Brain Research

Volumn 58, Issue 1-2, 1998, Pages 132-137

  Nakagawa, Yukinori ^a   Asai, Hiroshi ^a   Miura, Tomoko ^a   Kitoh, Junzoh ^b   Mori, Hitoshi ^a   Nakano, Kiwao ^a  

^a NAGOYA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3 Hydroxyanthranilate 3,4 dioxygenase; E1 mouse; Epilepsy; Excitotoxin; Quinolinic acid

Indexed keywords

3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; BRAIN ENZYME; COMPLEMENTARY DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DISEASE PREDISPOSITION; EPILEPSY; GENE EXPRESSION; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

3-HYDROXYANTHRANILATE 3,4-DIOXYGENASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CLONING, MOLECULAR; DIOXYGENASES; DISEASE MODELS, ANIMAL; DNA PRIMERS; DNA, COMPLEMENTARY; EPILEPSY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, NEUROLOGIC MUTANTS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; OPEN READING FRAMES; OXYGENASES; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; REFERENCE VALUES;

EID: 0032528094     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00119-3     Document Type: Article

References (41)

1. T.J. Bazett, R.C. Falik, J.B. Becker, R.L. Albin, Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat, Brain Res. Bull. 2 (1996) 68-73.
2. F. Block, M. Kunkel, M. Schwarz, Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats, Neurosci. Lett. 149 (1993) 126-128.
3. P. Chomczynski, N. Sacchi, Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162 (1987) 156-159.
4. I. Czubkowska, B. Karkowska, E. Najberg, C. Zychowicz, K. Nowacka, Epilepsy as a complication of bronchial asthma, Polski Tygodnik Lekarski. 49 (1994) 448-450.
5. C.L. Eastman, E.M. Urbanska, A.G. Chapman, R. Schwarcz, Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non epileptic mice, Epilepsy Res. 18 (1994) 185-194.
6. J.D. Ernst, J.M. Decazes, M.A. Sande, Experimental pneumococcal meningitis: role of leukocytes in pathogenesis, Infect. Immunol. 41 (1983) 275-279.
7. S. Feldblum, A. Ruogier, H. Liseau, F. Cohadon, P.L. Morselli, K.G. Lloyd, Quinolinic-phosphoribosyl transferase activity is decreased in epileptic human brain tissue, Epilepsia 29 (1988) 523-529.
8. H.J. Flavin, A. Wieraszko, T.N. Seyfried, Enhanced aspartate release from hippocampal slices of epileptic (El) mice, J. Neurochem. 56 (1991) 1007-1011.
9. A.C. Foster, J.F. Collins, R. Schwarcz, On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acid and structurally related compounds, Neuropharmacology 22 (1983) 1331-1342.
10. A.C. Foster, L.P. Miller, W.H. Oldendor, R. Schwarcz, Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat, Exp. Neurol. 84 (1984) 428-440.
11. A. Freese, M. DiFiglia, W.J. Koroshetz, M.F. Beal, J.B. Martin, Characterization and mechanism of glutamate neurotoxicity in primary striatal cultures, Brain Res. 521 (1990) 254-264.
12. C.E. Garey, A.L. Schwarzman, M.L. Rise, T.N. Seyfried, Ceruloplasmin gene defect associated with epilepsy in EL mice, Nature Genet. 6 (1994) 426-431.
13. M.P. Heyes, E.K. Jordan, K. Lee et al., Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid, Brain Res. 570 (1992) 237-250.
14. M.P. Heyes, K. Saito, J.S. Crowley et al., Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease, Brain 115 (1992) 1249-1273.
15. M.P. Heyes, A.R. Wyler, O. Devinsky et al., Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures, Epilepsia 31 (1990) 172-177.
16. Y. Ichihara, Y. Kurosawa, Construction of new T vectors for direct cloning of PCR products, Gene 130 (1993) 153-154.
17. N. Ishida, K. Kasamo, Y. Nakamoto, J. Suzuki, Epileptic seizure of El mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier, Brain Res. 608 (1993) 52-57.
18. C. Koehler, L.G. Ericksson, E. Okuno, R. Schwarcz, Localization of quinolinic acid metabolizing enzymes in the rat brain. Immunohistochemical studies using antibodies to 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyl transferase, Neuroscience 27 (1988) 49-76.
19. S. Koide, H. Onishi, M. Katayama, T. Kai, S. Yamagami, HPLC/RIA analysis of bioactive methionine enkephalin content in the seizure-susceptible El mouse brain, Neurochem. Res. 20 (1993) 1115-1118.
20. I.P. Lapin, Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships, Neuropharmacology 21 (1982) 1227-1233.
21. P. Malherbe, C. Koehler, M. Da Prada, G. Lang, V. Kiefer, R. Schwarcz, H.-W. Lahm, A.M. Cesura, Molecular cloning and functional expression of 3-hydroxyanthranilate 3,4-dioxygenase, J. Biol. Chem. 269 (1994) 13792-13797.
22. J.G. McLarnon, K. Curry, Quinolinate activation of N-methyl-D-aspartate ion channels in rat hippocampal neurons, Neurosci. Lett. 116 (1990) 341-346.
23. J.R. Moffett, M.G. Espey, S.J. Gaudet, M.A.A. Namboodiri, Antibodies to quinolinic acid reveal localization in select immune cells rather than neurons or astroglia, Brain Res. 623 (1993) 337-340.
24. K. Nakano, H. Asai, J. Kitoh, Abnormally high activity of 3-hydroxyanthranilate 3,4-dioxygenase in brain of epilepsy-prone El mice, Brain Res. 572 (1992) 1-4.
25. K. Nakano, S. Takahashi, M. Mizobuchi, T. Kuroda, K. Masuda, J. Kitoh, High levels of quinolinic acid in brain of epilepsy-prone El mice, Brain Res. 619 (1993) 195-198.
26. K. Oguro, M. Ito, H. Tsuda, K. Mutoh, H. Shiraishi, Y. Shirasaka, H. Mikawa, Association of NMDA receptor sites and seizures of El mice, Epilepsy Res. 9 (1991) 225-230.
27. E. Okuno, C. Koehler, R. Schwarcz, Rat 3-hydroxyanthranilate oxygenase: purification from the liver and immunocytochemical localization in the brain, J. Neurochem. 49 (1987) 771-780.
28. M.N. Perkins, T.W. Stone, Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system, J. Pharmacol. Exp. Ther. 22 (1983) 551-557.
29. R.C. Roberts, K.E. McCathy, F. Du, E. Okuno, R. Schwarcz, Immunocytochemical localization of quinolinic acid synthesizing enzyme, 3-hydroxyanthranilic acid oxygenase, in the rat substantia nigra, Brain Res. 650 (1994) 229-238.
30. K. Saito, S.P. Markey, M.P. Heyes, 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation, FEBS Lett. 178 (1994) 211-215.
31. K. Saito, T.S. Nowak Jr., S.P. Markey, M.P. Heyes, Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia, J. Neurochem. 60 (1993) 180-192.
32. A. Schurr, B.M. Rigor, Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro, Brain Res. 617 (1993) 76-80.
33. R. Schwarcz, G.S. Brush, A.C. Foster, E.D. French, Seizure activity and lesions after intrahippocampal quinolinic acid injection, Exp. Neurol. 84 (1984) 1-17.
34. R. Schwarcz, E. Okuno, R.J. White, E.D. Bird, 3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims, Proc. Natl. Acad. Sci. USA 85 (1988) 4079-4081.
35. Z. Suzel, T.M. Engber, S. Kuo, T.N. Chase, Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease, Neurosci. Lett. 121 (1991) 234-238.
36. S. Suzuki, A. Mori, Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice, Neurochem. Res. 17 (1992) 693-698.
37. K. Tsuzuki, M. Iino, S. Ozawa, Ion channels activated by quinolinic acid in cultured rat hippocampal neurons, Brain Res. 481 (1989) 258-264.
38. W.P. Todd, B.K. Carpenter, R. Schwarcz, Preparation of 4-halo-3-hydroxyanthranilates and demonstration of their inhibition of 3-hydroxyanthranilate oxygenase activity in rat and human brain tissue, Preparative Biochem. 19 (1989) 155-165.
39. A. Vezzani, H.-Q. Wu, M. Tulli, R. Samanin, Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments, J. Pharmacol. Exp. Ther. 239 (1986) 256-263.
40. Y. Yoneda, R. Enomoto, K. Ogita, H. Kabuto, A. Mori, Possible dysfunction of ionotropic glutamate receptors in cerebellum of epileptic El mice, Neurochem. Int. 25 (1994) 273-285.
41. Y. Yoneda, K. Ogita, H. Kabuto, A. Mori, Selectively high expression of the transcription factor API in telencephalic structures of epileptic El mice, Neurosci. Lett. 161 (1993) 161-164.